Borderline Resectable and Locally Advanced Pancreatic Cancer: FDG PET/MRI and CT Tumor Metrics for Assessment of Pathologic Response to Neoadjuvant Therapy and Prediction of Survival

Volume: 217, Issue: 3, Pages: 730 - 740
Published: Sep 1, 2021
Abstract
Borderline Resectable and Locally Advanced Pancreatic Cancer: FDG PET/MRI and CT Tumor Metrics for Assessment of Pathologic Response to Neoadjuvant Therapy and Prediction of SurvivalAnanya Panda, MD1, Ishan Garg, MBBS1, Mark J. Truty, MD2, Timothy L. Kline, PhD1, Matthew P. Johnson, MS3, Eric C. Ehman, MD1, Garima Suman, MD1, Deema A. Anaam, MBBS1, Bradley J. Kemp, PhD1, Geoffrey B. Johnson, MD, PhD1, Thorvardur R. Halfdanarson, MD4, Sudhakar K....
Paper Details
Title
Borderline Resectable and Locally Advanced Pancreatic Cancer: FDG PET/MRI and CT Tumor Metrics for Assessment of Pathologic Response to Neoadjuvant Therapy and Prediction of Survival
Published Date
Sep 1, 2021
Volume
217
Issue
3
Pages
730 - 740
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.